Black Seed Oil and Blood Sugar: What the Trials Actually Measured
Black seed oil and blood sugar is the most heavily studied pairing in the Nigella sativa literature — dozens of randomised trials, several meta-analyses, and a research interest going back decades. That is worth knowing. It is also not the same thing as saying black seed oil does anything for your blood sugar, and this article is not going to pretend otherwise. Black seed oil is a food supplement, not a medicine, and it is not a treatment for type 2 diabetes, pre-diabetes or anything else. What follows is a plain account of what those trials actually measured, how they were designed, where the evidence stops — and the one safety point that matters more than all of it.
For our own oil, see our cold-pressed Ethiopian black seed oil. For the wider picture, see our guide to what black seed oil does.
The Short Answer
- Black seed oil is a food supplement, not a medicine. It is not a treatment for diabetes or pre-diabetes, and nothing here should be read as a reason to change how a diagnosed condition is managed.
- The research is genuinely substantial. Glucose measures — fasting glucose, HbA1c, insulin resistance indices — are the outcomes most often chosen by trialists studying Nigella sativa, and several meta-analyses have pooled those trials.
- Almost all of that work was done in people already taking prescribed medication, with the supplement added on top. None of it tested Nigella sativa as a replacement for anything.
- Most trials used ground seed or encapsulated oil rather than a spoonful of cold-pressed oil, ran for a few months, and measured laboratory markers rather than long-term health outcomes.
- The safety point that matters: because so much of this research is built around glucose measures, an additive effect alongside insulin or oral glucose-lowering medication cannot be ruled out. Anyone on those medicines should speak to their GP or diabetes team before taking black seed oil at all.
- Sidr & Stone publishes a specific, independently verified figure of 2.67% thymoquinone, tested per batch by Analytice, an ISO-accredited French laboratory — a measured number, not a slogan.
What the Trials Were Actually Measuring
Before reading any result, it helps to know what was on the measuring stick. Trials in this area almost always report a handful of laboratory markers rather than how anyone felt or how long they lived.
- Fasting blood glucose — a single snapshot taken after an overnight fast.
- HbA1c — glycated haemoglobin, which reflects average blood glucose over the previous two to three months.
- Postprandial glucose — a reading two hours after a meal or a glucose load.
- HOMA-IR — an index calculated from fasting glucose and fasting insulin, used as a proxy for insulin resistance.
- Fasting insulin and C-peptide — indirect indicators of how hard the pancreas is working.
These are surrogate markers. They are useful, standard and cheap to measure, and clinicians take them seriously — but a shift in a marker over twelve weeks is not the same as a change in whether someone develops complications years later. Almost no Nigella sativa trial has been long enough or large enough to look at that second question, and it is honest to say so up front.
The Two Trials Everything Else Cites
Two studies from the same Saudi research group do most of the heavy lifting in this literature, and it is worth understanding them properly rather than through the summary of a summary.
The first, published by Bamosa and colleagues in the Indian Journal of Physiology and Pharmacology in 2010, randomised 94 people who were already taking oral glucose-lowering medication to one of three daily amounts of ground Nigella sativa seed for twelve weeks. It was a dose-comparison study rather than a placebo trial. The authors reported lower fasting glucose and lower HbA1c in the middle-dose group than at baseline, and — the detail most summaries omit — no additional change in the highest-dose group compared with the middle one.
The second, by Kaatabi and colleagues in PLOS ONE in 2015, is the stronger design: 114 people with type 2 diabetes, again all on their prescribed medication, randomised to Nigella sativa or a placebo for a full twelve months, with markers taken every three months. The authors reported lower fasting glucose and HbA1c in the supplemented group than in the placebo group, alongside changes in several oxidative-stress markers, and recorded no emerging safety signals over the year.
Two things follow. The design in both cases was supplement plus medication, never supplement instead of medication — so nothing in either study speaks to what would happen if someone stopped their prescription. And both used ground seed, not cold-pressed oil, which are not interchangeable materials.
What the Meta-Analyses Pooled — and What They Did Not
Several independent teams have pooled these trials. Daryabeygi-Khotbehsara and colleagues combined seven randomised trials in Complementary Therapies in Medicine in 2017. Saadati and colleagues pooled eleven trials in Frontiers in Nutrition in 2022. A 2025 dose-response meta-analysis by Jafari and colleagues in Pharmacological Research is the largest to date, drawing on 82 studies and 5,026 participants across daily amounts spanning 200mg to 4,600mg.
Read carefully, these reviews are more measured than the headlines they generate. The Saadati review reported differences in fasting plasma glucose and HbA1c between supplemented and placebo groups — but reported no significant difference in fasting insulin, in HOMA-IR, or in BMI, which is a mixed picture rather than a clean one. The 2025 review graded its own certainty formally and described Nigella sativa as a promising adjunct for further study, which is a researcher's phrase for "not settled".
The honest limits are worth naming plainly. Heterogeneity between trials is high, meaning the studies disagree with one another more than one would like. Most were small, most ran for twelve weeks or less, and a large share came from a handful of research groups in a small number of countries. Publication bias in supplement literature is a known problem. And the pooled trials mixed seed powder, encapsulated oil and standardised extracts as though they were one intervention. None of that makes the research worthless — it makes it early.
The Safety Point That Matters Most
This is the section to read if you read nothing else. Precisely because researchers keep choosing glucose measures as their outcome, the sensible working assumption is that an additive effect alongside glucose-lowering medication cannot be ruled out — and an additive effect in this particular direction is not a bonus. It is a hypoglycaemia risk.
Speak to your GP, diabetes nurse or endocrinologist before starting black seed oil if you take any of the following:
- Insulin, in any form.
- Sulfonylureas such as gliclazide, glimepiride or glipizide, which carry the highest hypoglycaemia risk of the oral options.
- Metformin, DPP-4 inhibitors, SGLT2 inhibitors or GLP-1 receptor agonists.
Your clinician may simply want you to test more often for a few weeks. That is a short conversation, and it is the difference between adding a supplement sensibly and finding out the hard way. The symptoms of low blood glucose — shakiness, sweating, confusion, a racing heart, sudden hunger, dizziness — are worth knowing regardless, and anyone who experiences them should follow the hypoglycaemia advice their diabetes team has already given them.
Two further points. Black seed oil is not a substitute for prescribed treatment, and no trial has ever tested it as one. And supplemental amounts are not recommended in pregnancy, which includes gestational diabetes — that is a conversation for your obstetric team, not a supplement decision. Our guide to black seed oil drug interactions and our side effects and safety guide cover the wider picture, including anticoagulants and antihypertensives.
The Objection Worth Taking Seriously
A fair reader will push back at this point: if the evidence is so hedged, why write about it at all? Two answers.
The first is that people are searching for this, and the alternative to an honest article is a dishonest one. A great deal of what is published on this topic quotes effect sizes as though they were guaranteed personal outcomes, and compares them to prescription medicines. That is not a small exaggeration; it is the kind of claim that could lead someone to take their medication less seriously.
The second is that the research genuinely is interesting on its own terms, and interesting is allowed to be the whole point. Thymoquinone has been studied in the laboratory for its antioxidant and anti-inflammatory behaviour, and that is why researchers keep designing metabolic trials around it. A mechanism observed in cells is a reason to investigate, not a result in a person — a distinction this article would rather over-state than blur.
The Variable Almost Nobody Publishes
If you do decide black seed oil belongs in your kitchen, there is one practical question worth more than any dosing table: what is actually in the bottle?
Thymoquinone content in commercial black seed products is wildly inconsistent. A 2022 analysis in Nutrients by Khaikin and colleagues screened eleven commercial Nigella sativa products by HPLC and found thymoquinone content spanning roughly 3 to 809 milligrams per 100 grams — a difference of more than two hundred-fold between the weakest and the strongest, across products a shopper could not tell apart. The authors argued for regulation of thymoquinone content in black seed products, which tells you how they viewed the spread.
That is why we treat a published, independently measured figure as the thing worth arguing about, rather than adjectives on a label. For how to check one properly, see our guide to choosing a quality black seed oil.
Why Sidr & Stone
We are not going to tell you our oil does anything for blood sugar, because we do not know that and neither does anyone else. What we can tell you is what is in it, and who measured it.
- Independently verified 2.67% thymoquinone, tested per batch by Analytice, an ISO-accredited French laboratory, with a Certificate of Analysis you can read.
- Organically grown Ethiopian highland Nigella sativa, selected through a 36-supplier evaluation that consistently returned the highest thymoquinone levels.
- Cold-pressed below 40°C, because thymoquinone is heat-sensitive.
- Unrefined and unfiltered — a single ingredient, nothing added. Natural fine sediment is normal.
- Bottled in matte black UV-protective glass, because light degrades thymoquinone as well as heat.
- Halal certified, with 10% of profits given to charity.
- A global brand, with fulfilment in the UK, EU, and US.
We will not tell you Sidr & Stone is the strongest or the best, and we will certainly not tell you it manages a metabolic condition. What we will say is that our thymoquinone figure is 2.67%, independently verified per batch, and the certificate is there for you to read.
Frequently Asked Questions
Does black seed oil affect blood sugar?
Black seed oil is a food supplement and is not a treatment for any blood-sugar condition. What can be said is that blood-glucose markers are the outcomes researchers have most often chosen when studying Nigella sativa, and several meta-analyses have pooled those trials. That is a description of where the research has looked, not a promise about what will happen to any individual.
Can I take black seed oil alongside diabetes medication?
Not without asking first. Speak to your GP, diabetes nurse or endocrinologist before starting, because an additive effect alongside insulin or oral glucose-lowering drugs cannot be ruled out and the consequence of that would be hypoglycaemia. Your clinician may want you to test more frequently for the first few weeks.
Can black seed oil replace my diabetes medication?
No, and no study has ever tested it that way. Every trial in this area added Nigella sativa on top of prescribed medication in people who stayed on their treatment. Stopping or reducing a prescription on the strength of a supplement is not something the evidence supports and not something we would ever suggest.
What did the trials actually use — oil or seeds?
Mostly ground seed or encapsulated oil rather than liquid cold-pressed oil. That matters, because a gram of ground seed, a gram of pressed oil and a gram of a concentrated extract are three different materials, and figures do not transfer cleanly between them.
Why is the evidence described as early if there are dozens of trials?
Because volume is not the same as quality. Most of these trials were small, ran for twelve weeks or less, came from a limited number of research groups, disagreed with one another more than reviewers would like, and measured laboratory markers rather than long-term health outcomes. Reviewers who have graded the certainty formally have been cautious for exactly those reasons.
Can black seed oil reverse type 2 diabetes?
No. It is a food supplement, not a medicine, and nothing in the literature supports that framing. Diet, physical activity, weight and prescribed treatment remain the things that determine how a metabolic condition is managed, under the care of a clinician.
Is it safe in pregnancy or while breastfeeding?
Supplemental amounts are not recommended in pregnancy, and safety data during breastfeeding is limited. Anyone pregnant — including with gestational diabetes — should raise it with their midwife or obstetric team rather than treating it as a supplement decision.
Is black seed oil a medicine?
No. Black seed oil is a food supplement, not a medicine. It has a long traditional history and an interesting body of research around thymoquinone, and can be a worthwhile part of a healthy routine — but it does not cure diseases and is not a substitute for medical care. Be cautious of any black seed oil marketed with specific disease-cure claims.
Final Thoughts
The literature on Nigella sativa and blood-glucose markers is real, reasonably large, and easy to misrepresent. Almost every exaggerated claim you will read on this subject comes from doing one of two things: treating a laboratory marker as though it were a health outcome, or treating a group average from a supervised trial as though it were a personal guarantee. Neither survives contact with the papers themselves.
What we would rather leave you with is the practical part. If you are managing a metabolic condition, the people to talk to are the ones who can see your notes. If you take glucose-lowering medication, have that conversation before you add anything, not after. And if you do choose to keep black seed oil in the cupboard as a food supplement, choose one whose thymoquinone content somebody has actually measured — because on that point, at least, the evidence is unambiguous that most bottles are not what they appear.
Our cold-pressed Ethiopian black seed oil — independently verified at 2.67% thymoquinone — is available now, with fulfilment in the UK, EU, and US.
Our black seed oil is pressed from organically grown Ethiopian highland Nigella sativa, but it is not certified organic: formal organic certification is hard to obtain in the Ethiopian highlands, so we tell you how the seed is grown rather than claim a certificate we do not hold.
Shop Sidr & Stone Cold-Pressed Ethiopian Black Seed Oil — Verified 2.67% Thymoquinone →
Disclaimer: This article describes what published research on Nigella sativa has measured at the time of writing; research findings may change, and readers should check current sources. Black seed oil is a food supplement, not a medicine, and is not a substitute for medical treatment of any condition. If you take insulin or any glucose-lowering medication, are pregnant or breastfeeding, or are managing a diagnosed condition, consult a qualified medical professional before taking black seed oil.